Please login to the form below

Not currently logged in
Email:
Password:

Aeterna Zentaris looks to Boehringer for science head

Richard Sachse joins Canadian firm as chief scientific officer
Aeterna Zenaris Richard Sachse

Aeterna Zentaris has appointed Boehringer Ingelheim's Dr Richard Sachse as senior VP and chief scientific officer.

Dr Sachse was most recently head of global translational medicine at Germany-based Boehringer following several roles at major pharma companies in Europe, including Bayer, Schwarz Pharma and UCB.

He will now make the move to Canada to take on his role at Aeterna Zentaris, which specialises in oncology and endocrinology.

The company's president and CEO David Dodd outline Dr Sachse's new role: “As CSO, he will be responsible for all areas of our global research and development activities, while also serving on the corporate operating committee.”

Dr Sachse said he was “delighted” by the opportunity his new position offered him.

He said: “I believe that the combination of Aeterna Zentaris' highly qualified and motivated personnel, together with its strong scientific platform, holds much promise for the future success of our projects."

8th January 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics